1 |
Yahalom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2015;92:11-31.
DOI
|
2 |
Fasola CE, Jones JC, Huang DD, Le QT, Hoppe RT, Donaldson SS. Low-dose radiation therapy (2 Gy 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys 2013;86:930-5.
DOI
|
3 |
Eng T, Ha CS. Image-guided radiation therapy in lymphoma management. Radiat Oncol J 2015;33:161-71.
DOI
|
4 |
Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol 2011;45:254-60.
DOI
|
5 |
White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995;102:1994-2006.
DOI
|
6 |
Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 2010;116:3815-24.
DOI
|
7 |
US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) version 4.0. Washington, DC: National Institutes of Health, National Cancer Institute; 2009.
|
8 |
Ferrufino-Ponce ZK, Henderson BA, Radiotherapy and cataract formation. Semin Ophthalmol 2006;21:171-80.
DOI
|
9 |
Swerdlow S, Campo E, Harris N, et al. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Geneva: World Health Organization; 2008.
|
10 |
Hata M, Omura M, Koike I, et al. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys 2011;81:1387-93.
DOI
|
11 |
Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
|
12 |
Ejima Y, Sasaki R, Okamoto Y, et al. Ocular adnexal mucosaassociated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol 2006;78:6-9.
DOI
|
13 |
Platt S, Al Zahrani Y, Singh N, Hill B, Cherian S, Singh AD. Extranodal marginal zone lymphoma of ocular adnexa: outcomes following radiation therapy. Ocul Oncol Pathol 2017;3:181-7.
DOI
|
14 |
Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY, Hahn JS. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 2006;65:228-33.
DOI
|
15 |
Harada K, Murakami N, Kitaguchi M, et al. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 2014;88:650-4.
DOI
|
16 |
Goda JS, Le LW, Lapperriere NJ, et al. Localized orbital mucosaassociated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys 2011;81:e659-66.
DOI
|
17 |
Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa. Cancer 2003;98:865-71.
DOI
|
18 |
Hashimoto N, Sasaki R, Nishimura H, et al. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2012;82:1509-14.
DOI
|
19 |
Nam H, Ahn YC, Kim YD, Ko Y, Kim WS. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol 2009;90:236-41.
DOI
|
20 |
Monzen Y, Hasebe H. Radiotherapy for localized orbital mucosa-associated lymphoid tissue lymphoma. Ophthalmologica 2007;221:233-7.
DOI
|
21 |
Lee JL, Kim MK, Lee KH, et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 2005;84:13-8.
DOI
|
22 |
Tran KH, Campbell BA, Fua T, et al. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma. Leuk Lymphoma 2013;54:491-6.
DOI
|
23 |
Javitt JC, Wang F, West SK. Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health 1996;17:159-77.
DOI
|
24 |
Ohga S, Nakamura K, Shioyama Y, et al. Radiotherapy for early-stage primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. Anticancer Res 2013;33:5575-8.
|
25 |
Leske MC, Chylack LT Jr, Wu SY. The lens opacities casecontrol study: risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
DOI
|